Divalproex Sodium ER

CHEBI:CHEBI_756816

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
1099569
product_type
HUMAN PRESCRIPTION DRUG
route
ORAL
marketing_category
ANDA
listing_expiration_date
20241231
pharm_class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
dosage_form
TABLET, EXTENDED RELEASE
active_ingredient_strength
500 mg/1
application_number
ANDA209286
active_ingredient_name
DIVALPROEX SODIUM
unii
644VL95AO6
marketing_start_date
20230403
package_marketing_start_date
20230403
labeler_name
Direct_Rx
manufacturer_name
Direct_Rx
generic_name
Divalproex Sodium ER
brand_name
Divalproex Sodium ER
brand_name_base
Divalproex Sodium ER
product_ndc
72189-459
spl_id
f86f185b-4acc-43b5-e053-6394a90a681c
package_ndc
72189-459-60
package_description
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (72189-459-60)
spl_set_id
f86f185b-4acb-43b5-e053-6394a90a681c
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class